Literature DB >> 12230111

Suppression of NO production in activated macrophages in vitro and ex vivo by neoandrographolide isolated from Andrographis paniculata.

Javzan Batkhuu1, Koichi Hattori, Fumihide Takano, Shinji Fushiya, Ko-ichi Oshiman, Yoshiaki Fujimiya.   

Abstract

In this study, we investigated the in vitro and ex vivo suppressive effects of Andrographis paniculata on nitric oxide (NO) production in mouse peritoneal macrophages elicited by bacillus Calmette-Guéin (BCG) and stimulated by lipopolysaccharide (LPS). Incubation of BCG-induced macrophages with the methanol extract of A. paniculata reduced LPS stimulated NO production. The diterpene lactones andrographolide and neoandrographolide were isolated as active components from the extract. These compounds suppressed NO production in a concentration-dependent manner in the concentration range from 0.1 to 100 microM and their IC50 values were 7.9 and 35.5 microM. Neoandrographolide also suppressed NO production by 35 and 40% when the macrophages were collected after oral administration of neoandrographolide at doses of 5 and 25 mg/kg/d and LPS stimulated NO production was examined. However, andrographolide did not reduce NO production on oral administration at the same doses. These results indicate that neoandrographolide, which inhibited NO production both in vitro and ex vivo may play an important role in the use of A. paniculata as an anti-inflammatory crude drug.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230111     DOI: 10.1248/bpb.25.1169

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  22 in total

1.  Anti-cancer labdane diterpenoids from adventitious roots of Andrographis paniculata: augmentation of production prospect endowed with pathway gene expression.

Authors:  Sailendra Singh; Pallavi Pandey; Sumit Ghosh; Suchitra Banerjee
Journal:  Protoplasma       Date:  2018-03-20       Impact factor: 3.356

2.  Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian).

Authors:  Wen-Wan Chao; Bi-Fong Lin
Journal:  Chin Med       Date:  2010-05-13       Impact factor: 5.455

3.  HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1/TH17 responses.

Authors:  Kathrin S Michelsen; Michelle H Wong; Brian Ko; Lisa S Thomas; Deepti Dhall; Stephan R Targan
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

4.  Network pharmacology integrated with experimental validation revealed the anti-inflammatory effects of Andrographis paniculata.

Authors:  Naiqiang Zhu; Jingyi Hou; Ning Yang
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

5.  Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB.

Authors:  Tao Zhu; Dao-xin Wang; Wei Zhang; Xiu-qing Liao; Xian Guan; Hong Bo; Jia-yang Sun; Ni-wen Huang; Jing He; Yun-kun Zhang; Jing Tong; Chang-yi Li
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

6.  A pH-responsive mesoporous silica nanoparticles-based drug delivery system with controlled release of andrographolide for OA treatment.

Authors:  Mingwei He; Zainen Qin; Xiaonan Liang; Xixi He; Bikang Zhu; Zhenhui Lu; Qingjun Wei; Li Zheng
Journal:  Regen Biomater       Date:  2021-06-30

7.  Metabolomic and Pharmacologic Insights of Aerial and Underground Parts of Glycyrrhiza uralensis Fisch. ex DC. for Maximum Utilization of Medicinal Resources.

Authors:  Liang Jiang; Waheed Akram; Biaobiao Luo; Sheng Hu; Mohammad Omar Faruque; Shakeel Ahmad; Nasim Ahmad Yasin; Waheed Ullah Khan; Aqeel Ahmad; Alexander N Shikov; Jian Chen; Xuebo Hu
Journal:  Front Pharmacol       Date:  2021-06-01       Impact factor: 5.810

8.  A biochemical study on the gastroprotective effect of andrographolide in rats induced with gastric ulcer.

Authors:  P Saranya; A Geetha; S M K Narmadha Selvamathy
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

9.  Changes in the contents of four active diterpenoids at different growth stages in Andrographis paniculata (Burm.f.) Nees (Chuanxinlian).

Authors:  Nanthanit Pholphana; Nuchanart Rangkadilok; Jittra Saehun; Supachai Ritruechai; Jutamaad Satayavivad
Journal:  Chin Med       Date:  2013-01-15       Impact factor: 5.455

10.  Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide.

Authors:  Thanasekaran Jayakumar; Cheng-Ying Hsieh; Jie-Jen Lee; Joen-Rong Sheu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.